The 2025 FBIF Food Innovation Exhibition was held from May 8 to 10 at the National Exhibition and Convention Center (Shanghai). XinTianhe Bio-tech showcased its AKG series products at booths 5.2B216, B217, and B218, engaging with numerous domestic and international clients in the food and beverage industry to discuss new paradigms of intelligent innovation in functional ingredients, demonstrating its technological innovation capabilities.
Figure: XinTianhe Bio-tech Exhibition Booth
At the exhibition, XinTianhe Bio-tech presented five featured products, including α-Ketoglutarate (AKG), Calcium Ketoglutarate (Ca-AKG), L-Arginine-α-Ketoglutarate, Ornithine-α-Ketoglutarate, and 5-Aminolevulinic Acid Hydrochloride.
Among them, the AKG product attracted numerous merchants for inquiries. AKG is a metabolite of the tricarboxylic acid cycle (TCA cycle), involved in cellular energy metabolism and protein synthesis.
Its unique mechanism of action and China's first synthetic biology whole-cell catalysis technology enable AKG to demonstrate exceptional efficacy and vast market application potential in numerous fields such as anti-aging skincare, sports nutrition, bone health, and cosmetic care.
Figure: AKG Sample Display
CynbioX®AKG
XinTianhe Bio-tech utilizes whole-cell catalysis to produce CynbioX®AKG with a high content of over 99%. Its unique production process ensures fewer impurities; no organic solvents are used during production, guaranteeing a greener and safer product. Experimental tests confirm that CynbioX®AKG has higher biological activity and more defined efficacy.
